Sacyr S.A. buy krebskrebs
Start price
17.05.20
/
50%
€1.55
Target price
04.11.21
€1.92
Performance (%)
45.99%
End price
05.11.21
€2.27
Summary
This prediction ended on 05.11.21 with a price of €2.27. With a performance of 45.99% the BUY prediction by krebskrebs was a big success. A total of €0.066 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sacyr S.A. | -2.822% | -2.822% | 9.109% | 55.066% |
iShares Core DAX® | -1.785% | -1.250% | 11.664% | 12.714% |
iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% | 41.653% |
iShares Nikkei 225® | -4.028% | -3.746% | 17.142% | 0.393% |
iShares S&P 500 | -1.969% | 0.307% | 25.617% | 40.084% |
Comments by krebskrebs for this prediction
In the thread Sacyr S.A. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Sacyr S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten